Table 1. Clinicopathologic characteristics and DACH1 methylation status of 104 patients with esophageal squamous cell carcimoma.
Methylation status | ||||
Clinical parameter | No. | Methylated | Unmethylated | P value* |
n = 64 (61.5%) | n = 40 (38.5%) | |||
Age (year) | ||||
<50 | 27 | 14 (51.9%) | 13 (48.1%) | P = 0.2292 |
≥50 | 77 | 50 (64.9%) | 27 (35.1%) | |
Gender | ||||
Male | 82 | 47 (57.3%) | 35 (42.7%) | P = 0.0876 |
Female | 22 | 17 (77.3%) | 5 (22.7%) | |
Differentiation | ||||
Poorly | 45 | 34 (75.6%) | 11 (24.4%) | P = 0.0103# |
Moderately/Well | 59 | 30 (50.9%) | 29 (49.1%) | |
Tumor stage | ||||
I/II | 71 | 39 (54.9%) | 32 (45.1%) | P = 0.0422# |
III/IV | 33 | 25 (75.8%) | 8 (24.2%) | |
Metastasis | ||||
Negative | 69 | 39 (56.5%) | 30 (43.5%) | P = 0.1398 |
Positive | 35 | 25 (71.4%) | 10 (28.6%) | |
Tumor size | ||||
≥5 cm | 33 | 18 (54.6%) | 15 (45.4%) | P = 0.3176 |
<5 cm | 71 | 46 (64.8%) | 25 (35.2%) |
*P values are obtained from chi-square test.
Statistical significance is indicated by P<0.05.